245 related articles for article (PubMed ID: 29542045)
1. Electroretinogram evaluation for the treatment of proliferative diabetic retinopathy by short-pulse pattern scanning laser panretinal photocoagulation.
Ye H; Yu M; Lu L; Jin C; Luo G
Lasers Med Sci; 2018 Jul; 33(5):1095-1102. PubMed ID: 29542045
[TBL] [Abstract][Full Text] [Related]
2. Retinal function in eyes with proliferative diabetic retinopathy treated with intravitreal ranibizumab and multispot laser panretinal photocoagulation.
Messias K; Barroso RM; Jorge R; Messias A
Doc Ophthalmol; 2018 Oct; 137(2):121-129. PubMed ID: 30209775
[TBL] [Abstract][Full Text] [Related]
3. Comparison of functional changes of retina after subthreshold and threshold pan-retinal photocoagulation in severe non-proliferative diabetic retinopathy.
Zhao H; Zhou L; Lai K; Yu M; Huang C; Xu F; Li C; Lu L; Jin C
Lasers Med Sci; 2022 Dec; 37(9):3561-3569. PubMed ID: 36070046
[TBL] [Abstract][Full Text] [Related]
4. Single-session vs multiple-session pattern scanning laser panretinal photocoagulation in proliferative diabetic retinopathy: The Manchester Pascal Study.
Muqit MM; Marcellino GR; Henson DB; Young LB; Patton N; Charles SJ; Turner GS; Stanga PE
Arch Ophthalmol; 2010 May; 128(5):525-33. PubMed ID: 20457972
[TBL] [Abstract][Full Text] [Related]
5. Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy.
Messias A; Ramos Filho JA; Messias K; Almeida FP; Costa RA; Scott IU; Gekeler F; Jorge R
Doc Ophthalmol; 2012 Jun; 124(3):225-36. PubMed ID: 22457045
[TBL] [Abstract][Full Text] [Related]
6. Extended targeted retinal photocoagulation versus conventional pan-retinal photocoagulation for proliferative diabetic retinopathy in a randomized clinical trial.
Nikkhah H; Ghazi H; Razzaghi MR; Karimi S; Ramezani A; Soheilian M
Int Ophthalmol; 2018 Feb; 38(1):313-321. PubMed ID: 28168567
[TBL] [Abstract][Full Text] [Related]
7. Pascal panretinal laser ablation and regression analysis in proliferative diabetic retinopathy: Manchester Pascal Study Report 4.
Muqit MM; Marcellino GR; Henson DB; Young LB; Turner GS; Stanga PE
Eye (Lond); 2011 Nov; 25(11):1447-56. PubMed ID: 21818132
[TBL] [Abstract][Full Text] [Related]
8. Pilot randomised clinical trial of Pascal TargETEd Retinal versus variable fluence PANretinal 20 ms laser in diabetic retinopathy: PETER PAN study.
Muqit MM; Young LB; McKenzie R; John B; Marcellino GR; Henson DB; Turner GS; Stanga PE
Br J Ophthalmol; 2013 Feb; 97(2):220-7. PubMed ID: 23178855
[TBL] [Abstract][Full Text] [Related]
9. Central retinal thickness following panretinal photocoagulation using a multispot semi-automated pattern-scanning laser to treat ischaemic diabetic retinopathy: Treatment in one session compared with four monthly sessions.
Gabrielle PH; Massin P; Kodjikian L; Erginay A; Pallot C; Jonval L; Soudry A; Couturier A; Vardanian-Vartin C; Bron AM; Creuzot-Garcher C
Acta Ophthalmol; 2019 Aug; 97(5):e680-e687. PubMed ID: 30561087
[TBL] [Abstract][Full Text] [Related]
10. Proliferative diabetic retinopathy treated with intravitreal ranibizumab and photocoagulation directed at ischemic retinal areas-A randomized study.
Toscano L; Messias A; Messias K; de Cenço Lopes R; Ribeiro JAS; Scott IU; Jorge R
Doc Ophthalmol; 2021 Dec; 143(3):313-322. PubMed ID: 34347216
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy of navigated panretinal photocoagulation in proliferative diabetic retinopathy.
Chhablani J; Sambhana S; Mathai A; Gupta V; Arevalo JF; Kozak I
Am J Ophthalmol; 2015 May; 159(5):884-9. PubMed ID: 25703478
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of multifocal electroretinography and optical coherence tomography in eyes undergoing panretinal photocoagulation for diabetic retinopathy.
Zhu Y; Zhang T; Wang KY; Xu GZ
Invest Ophthalmol Vis Sci; 2014 Aug; 55(10):6358-64. PubMed ID: 25146984
[TBL] [Abstract][Full Text] [Related]
13. Comparison of conventional pattern and novel navigated panretinal photocoagulation in proliferative diabetic retinopathy.
Chhablani J; Mathai A; Rani P; Gupta V; Arevalo JF; Kozak I
Invest Ophthalmol Vis Sci; 2014 May; 55(6):3432-8. PubMed ID: 24787564
[TBL] [Abstract][Full Text] [Related]
14. Study of clinical applications and safety for Pascal® laser photocoagulation in retinal vascular disorders.
Muqit MM; Sanghvi C; McLauchlan R; Delgado C; Young LB; Charles SJ; Marcellino GR; Stanga PE
Acta Ophthalmol; 2012 Mar; 90(2):155-61. PubMed ID: 20163363
[TBL] [Abstract][Full Text] [Related]
15. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.
Royle P; Mistry H; Auguste P; Shyangdan D; Freeman K; Lois N; Waugh N
Health Technol Assess; 2015 Jul; 19(51):v-xxviii, 1-247. PubMed ID: 26173799
[TBL] [Abstract][Full Text] [Related]
16. Randomized clinical trial to evaluate the effects of Pascal panretinal photocoagulation on macular nerve fiber layer: Manchester Pascal Study report 3.
Muqit MM; Marcellino GR; Henson DB; Fenerty CH; Stanga PE
Retina; 2011 Sep; 31(8):1699-707. PubMed ID: 21478808
[TBL] [Abstract][Full Text] [Related]
17. Comparison of pain scores between patients undergoing panretinal photocoagulation using navigated or pattern scan laser systems.
Inan UU; Polat O; Inan S; Yigit S; Baysal Z
Arq Bras Oftalmol; 2016 Feb; 79(1):15-8. PubMed ID: 26840160
[TBL] [Abstract][Full Text] [Related]
18. Changes in peripapillary retinal nerve fiber layer thickness after pattern scanning laser photocoagulation in patients with diabetic retinopathy.
Park YR; Jee D
Korean J Ophthalmol; 2014 Jun; 28(3):220-5. PubMed ID: 24882955
[TBL] [Abstract][Full Text] [Related]
19. Electroretinogram Changes Following Sequential Panretinal Photocoagulation for Proliferative Diabetic Retinopathy.
Khojasteh H; Amini Vishte R; Mirzajani A; Khalili Pour E; Bazvand F; Riazi-Esfahani H; Mirghorbani M; Modjtahedi BS
Clin Ophthalmol; 2020; 14():967-975. PubMed ID: 32280191
[TBL] [Abstract][Full Text] [Related]
20. Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study).
Tonello M; Costa RA; Almeida FP; Barbosa JC; Scott IU; Jorge R
Acta Ophthalmol; 2008 Jun; 86(4):385-9. PubMed ID: 17995982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
